Marlan D. Walker - Mar 14, 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
General Counsel
Signature
/s/ Marlan D. Walker
Stock symbol
TXMD
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
3/15/2022, 07:00 AM
Previous filing
Oct 1, 2021
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +230K +795.63% 259K Mar 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -230K -100% $0.00* 0 Mar 14, 2022 Common Stock 230K $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021.
F2 Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F3 The RSUs vested on December 13, 2021.